Table 2.
Outcome differences between patients admitted for middle cerebral artery strokes before and during the pandemic (2019 vs 2020)
| Total (N=17 103) | Pre-pandemic (N=8291) | During the pandemic (N=8812) | P value | |
| Mean length of stay (LOS) in days (SD) | 8.2 (10.0) | 8.1 (9.2) | 8.3 (10.8) | 0.239 |
| Subarachnoid haemorrhage | 993 (5.8%) | 472 (5.7%) | 521 (5.9%) | 0.540 |
| Intracranial haemorrhage | 2945 (17.2%) | 1422 (17.2%) | 1523 (17.3%) | 0.819 |
| Intraventricular haemorrhage | 270 (1.6%) | 128 (1.5%) | 142 (1.6%) | 0.723 |
| Vasospasm | 150 (0.9%) | 70 (0.8%) | 80 (0.9%) | 0.656 |
| Access site haemorrhage | 174 (1.0%) | 98 (1.2%) | 76 (0.9%) | 0.037 |
| Haematoma | 74 (0.4%) | 35 (0.4%) | 39 (0.4%) | 0.839 |
| Wound dehiscence | 15 (0.1%) | 5 (0.1%) | 10 (0.1%) | 0.240 |
| Vascular catheter infection | 12 (0.1%) | 7 (0.1%) | 5 (0.1%) | 0.494 |
| Thromboembolic events | 901 (5.3%) | 424 (5.1%) | 477 (5.4%) | 0.382 |
| Acute kidney injury | 2986 (17.5%) | 1360 (16.4%) | 1626 (18.5%) | <0.001 |
| Neurological complications | 94 (0.5%) | 48 (0.6%) | 46 (0.5%) | 0.615 |
| Respiratory complications | 1084 (6.3%) | 491 (5.9%) | 593 (6.7%) | 0.030 |
| Cardiac complications | 92 (0.5%) | 43 (0.5%) | 49 (0.6%) | 0.738 |
| Urinary complications | 2986 (17.5%) | 1360 (16.4%) | 1626 (18.5%) | <0.001 |
| Non-routine discharge | 13 099 (76.6%) | 6310 (76.1%) | 6789 (77.1%) | 0.149 |
| In-hospital mortality | 1646 (9.6%) | 748 (9.0%) | 898 (10.2%) | 0.010 |
Bold indicates statistically significant p-values (p<0.05).